UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008142
Receipt number R000009427
Scientific Title Effect of the prebiotics taken by pregnant and lactating women on the immunoactive substance in the breast milk and bowel movement
Date of disclosure of the study information 2012/07/01
Last modified on 2012/12/16 19:00:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of the prebiotics taken by pregnant and lactating women on the immunoactive substance in the breast milk and bowel movement

Acronym

The effect of the prebiotics on mothers' milk

Scientific Title

Effect of the prebiotics taken by pregnant and lactating women on the immunoactive substance in the breast milk and bowel movement

Scientific Title:Acronym

The effect of the prebiotics on mothers' milk

Region

Japan


Condition

Condition

pregnant woman

Classification by specialty

Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To check the prebiotics medication to a pregnant woman influence the immunoactive agents in breastmilk, bowel movement of pregnant woman, and the development of allergic diseases of children.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

cytokines, IgA and sCD14 in breastmilk

Key secondary outcomes

1. Specific and non specific IgE in mother's blood and umbilical cord blood.
2. Profile of gene expression in white blood cells in breastmilk
3. Changes in bowel habit
4. Changes in intestinal flora of mothers
5. Existence of allergic diseases of chilren at the age of six month


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

prebiotics

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

normal pregnant woman

Key exclusion criteria

1. The pregnant woman who need whole body control for toxemia of pregnancy or other diseases during pregnancy progress.
2. The pregnant woman who were judged to be unsuitable from efficacy and safety by doctor.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Shimojo

Organization

Graduate School of Medicine, Chiba University

Division name

Pediatrics

Zip code


Address

1-8-1 Inohana Chuou-ku Chiba city

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Naoki Shimojo

Organization

Graduate School of Medicine, Chiba University

Division name

Pediatrics

Zip code


Address


TEL

043-226-5364

Homepage URL


Email



Sponsor or person

Institute

Graduate School of Medicine, Chiba University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

増田産婦人科(千葉県)


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 08 Month 26 Day

Date of IRB


Anticipated trial start date

2009 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 06 Month 11 Day

Last modified on

2012 Year 12 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009427


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name